DECR1
Basic information
Region (hg38): 8:90001405-90053633
Previous symbols: [ "DECR" ]
Links
Phenotypes
GenCC
Source:
- progressive encephalopathy with leukodystrophy due to DECR deficiency (Limited), mode of inheritance: Unknown
- liver disorder (Limited), mode of inheritance: AR
- progressive encephalopathy with leukodystrophy due to DECR deficiency (No Known Disease Relationship), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| 2,4-dienoyl-CoA reductase deficiency | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic | 2332510 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (36 variants)
- Progressive_encephalopathy_with_leukodystrophy_due_to_DECR_deficiency (8 variants)
- DECR1-related_disorder (4 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DECR1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001359.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 34 | 40 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 34 | 8 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DECR1 | protein_coding | protein_coding | ENST00000220764 | 10 | 50688 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.47e-14 | 0.00688 | 125626 | 0 | 120 | 125746 | 0.000477 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.0316 | 180 | 181 | 0.993 | 0.00000890 | 2175 |
| Missense in Polyphen | 69 | 76.171 | 0.90586 | 845 | ||
| Synonymous | 0.561 | 56 | 61.6 | 0.909 | 0.00000320 | 678 |
| Loss of Function | -0.582 | 19 | 16.5 | 1.15 | 7.79e-7 | 205 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000799 | 0.000793 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000391 | 0.000381 |
| Finnish | 0.000185 | 0.000185 |
| European (Non-Finnish) | 0.000238 | 0.000237 |
| Middle Eastern | 0.000391 | 0.000381 |
| South Asian | 0.00173 | 0.00173 |
| Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Auxiliary enzyme of beta-oxidation. It participates in the metabolism of unsaturated fatty enoyl-CoA esters having double bonds in both even- and odd-numbered positions. Catalyzes the NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3- enoyl-CoA.;
- Pathway
- Fatty Acid Beta Oxidation;Fatty Acid Biosynthesis;Liver steatosis AOP;ccr3 signaling in eosinophils;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;3-oxo-10R-octadecatrienoate beta-oxidation;Metabolism;Fatty acid metabolism;Omega-6 fatty acid metabolism;Di-unsaturated fatty acid beta-oxidation
(Consensus)
Recessive Scores
- pRec
- 0.936
Intolerance Scores
- loftool
- 0.640
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.467
- hipred
- Y
- hipred_score
- 0.564
- ghis
- 0.435
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.924
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Decr1
- Phenotype
- liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- fatty acid beta-oxidation;protein homotetramerization;positive regulation of cold-induced thermogenesis
- Cellular component
- nucleus;nucleoplasm;mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- 2,4-dienoyl-CoA reductase (NADPH) activity;oxidoreductase activity, acting on NAD(P)H;NADPH binding